TABLE 3.
CD4+-T-cell epitopes identified in LMP1 and LMP2a
Antigen and aa | Epitope sequence | No. of responders | Potential restrictionb
|
|
---|---|---|---|---|
DR | DQ | |||
LMP1 | ||||
130–144 | LWRLGATIWQLLAFF | 1 | 1, 4 | 1, 3 |
212–226 | SGHESDSNSNEGRHH | 3 | 2 | |
340–354 | TDGGGGHSHDSGHGG | 1 | NDc | ND |
LMP2 | ||||
149–163 | STVVTATGLALSLLL | 2 | 1, 13 | 5 |
169–182 | SSYAAAQRKLLTPV | 2 | 1, 13 | 5, 6 |
224–243 | VLVMLVLLILAYRRRWRRLT | 2 | None | None |
385–398 | STEFIPNLFCMLLL | 1 | ND | ND |
The sequences of LMP1 and LMP2 are derived from the B95.8 prototype strain of EBV.
Potential restriction elements were identified as described for Table 1.
ND, not determined.